Department of Surgery, Yonsei University College of Medicine, 134, Sinchon-dong, Seodaemum-gu, Seoul, 120-75, Korea.
World J Surg. 2013 Apr;37(4):829-37. doi: 10.1007/s00268-013-1909-9.
In patients with Bismuth type I and II hilar cholangiocarcinoma (HCCA), bile duct resection alone has been the conventional approach. However, many authors have reported that concomitant liver resection improved surgical outcomes.
Between January 2000 and January 2012, 52 patients underwent surgical resection for a Bismuth type I and II HCCA (type I: n = 22; type II: n = 30). Patients were classified into two groups: concomitant liver resection (n = 26) and bile duct resection alone (n = 26).
Bile duct resection alone was performed in 26 patients. Concomitant liver resection was performed in 26 patients (right side hepatectomy [n = 13]; left-side hepatectomy [n = 6]; volume-preserving liver resection [n = 7]). All liver resections included a caudate lobectomy. Patient and tumor characteristics did not differ between the two groups. Although concomitant liver resection required longer operating time (P < 0.001), it had a similar postoperative complication rate (P = 0.764), high curability (P = 0.010), and low local recurrence rate (P = 0.006). Concomitant liver resection showed better overall survival (P = 0.047).
Concomitant liver resection should be considered in patients with Bismuth type I and II HCCA.
在伴有Ⅰ型和Ⅱ型肝门部胆管癌(HCCA)的患者中,单独胆管切除术一直是常规方法。然而,许多作者报告称,同时进行肝切除术可改善手术结果。
在 2000 年 1 月至 2012 年 1 月期间,52 例 Bismuth Ⅰ型和Ⅱ型 HCCA 患者接受了手术切除(Ⅰ型:n=22;Ⅱ型:n=30)。患者分为两组:同时行肝切除术(n=26)和单纯胆管切除术(n=26)。
单纯胆管切除术在 26 例患者中进行。26 例患者同时行肝切除术(右半肝切除术[n=13];左半肝切除术[n=6];保留肝脏体积切除术[n=7])。所有肝切除术均包括尾状叶切除术。两组患者的一般情况和肿瘤特征无差异。尽管同时行肝切除术需要更长的手术时间(P<0.001),但其术后并发症发生率相似(P=0.764),治愈率高(P=0.010),局部复发率低(P=0.006)。同时行肝切除术的总生存情况更好(P=0.047)。
对于伴有Ⅰ型和Ⅱ型肝门部胆管癌的患者,应考虑同时行肝切除术。